GlaxoSmithKline is to shed hundreds of U.S. commercial and research jobs, restructuring operations in its biggest market where drug sales are flagging. A total of 900 posts will be eliminated at GSK’s …
GlaxoSmithKline is to shed hundreds of U.S. commercial and research jobs, restructuring operations in its biggest market where drug sales are flagging. A total of 900 posts will be eliminated at GSK’s …